Category: Cancer Treatment
Cancer Treatment market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Breast Cancer Diagnostic Products
The 2025-2030 World Outlook for Breast Cancer Diagnostic Products This study covers the world outlook for breast cancer diagnostic products across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More
-
The 2025-2030 World Outlook for Breast Cancer Diagnostics
The 2025-2030 World Outlook for Breast Cancer Diagnostics This study covers the world outlook for breast cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More
-
The 2025-2030 World Outlook for Breast Cancer Monoclonal Antibodies (mAb)
The 2025-2030 World Outlook for Breast Cancer Monoclonal Antibodies (mAb) This study covers the world outlook for breast cancer monoclonal antibodies (mAb) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for ... Read More
-
The 2025-2030 World Outlook for Breast Cancer Therapeutics
The 2025-2030 World Outlook for Breast Cancer Therapeutics This study covers the world outlook for breast cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
-
The 2025-2030 World Outlook for Breast Cancer Screenings
The 2025-2030 World Outlook for Breast Cancer Screenings This study covers the world outlook for breast cancer screenings across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2025-2030 World Outlook for Kaposi Sarcomas
The 2025-2030 World Outlook for Kaposi Sarcomas This study covers the world outlook for Kaposi sarcomas across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars ... Read More
-
The 2025-2030 World Outlook for Esophageal Cancer Monoclonal Antibodies (mAb)
The 2025-2030 World Outlook for Esophageal Cancer Monoclonal Antibodies (mAb) This study covers the world outlook for esophageal cancer monoclonal antibodies (mAb) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E ... Read More
-
The 2025-2030 World Outlook for Prostate Cancer Diagnostics
The 2025-2030 World Outlook for Prostate Cancer Diagnostics This study covers the world outlook for prostate cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More
-
The 2025-2030 World Outlook for Prostate Cancer Nuclear Medicine Diagnostics
The 2025-2030 World Outlook for Prostate Cancer Nuclear Medicine Diagnostics This study covers the world outlook for prostate cancer nuclear medicine diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.) ... Read More
-
The 2025-2030 World Outlook for Cancer Profiling and Pathways
The 2025-2030 World Outlook for Cancer Profiling and Pathways This study covers the world outlook for cancer profiling and pathways across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More
-
The 2025-2030 World Outlook for Cancer and Tumor Profiling
The 2025-2030 World Outlook for Cancer and Tumor Profiling This study covers the world outlook for cancer and tumor profiling across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
-
The 2025-2030 World Outlook for Gynaecological Cancer Drugs
The 2025-2030 World Outlook for Gynaecological Cancer Drugs This study covers the world outlook for gynaecological cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More
-
The 2025-2030 World Outlook for Cancer Biologics
The 2025-2030 World Outlook for Cancer Biologics This study covers the world outlook for cancer biologics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More
-
The 2025-2030 World Outlook for Cancer Liquid Biopsy Products
The 2025-2030 World Outlook for Cancer Liquid Biopsy Products This study covers the world outlook for cancer liquid biopsy products across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More
-
The 2025-2030 World Outlook for Cancer Pain
The 2025-2030 World Outlook for Cancer Pain This study covers the world outlook for cancer pain across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the p ... Read More
-
The 2025-2030 World Outlook for Cancer Pain Management
The 2025-2030 World Outlook for Cancer Pain Management This study covers the world outlook for cancer pain management across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for Head and Neck Cancer Diagnostics
The 2025-2030 World Outlook for Head and Neck Cancer Diagnostics This study covers the world outlook for head and neck cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in que ... Read More
-
The 2025-2030 World Outlook for Colorectal Cancer Chemotherapy Therapeutics
The 2025-2030 World Outlook for Colorectal Cancer Chemotherapy Therapeutics This study covers the world outlook for colorectal cancer chemotherapy therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ... Read More
-
The 2025-2030 World Outlook for Therapeutic Cancer Vaccines
The 2025-2030 World Outlook for Therapeutic Cancer Vaccines This study covers the world outlook for therapeutic cancer vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More
-
The 2025-2030 World Outlook for Breast Cancer Liquid Biopsies
The 2025-2030 World Outlook for Breast Cancer Liquid Biopsies This study covers the world outlook for breast cancer liquid biopsies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More
-
The 2025-2030 World Outlook for Germcitabine HCI
The 2025-2030 World Outlook for Germcitabine HCI This study covers the world outlook for germcitabine HCI across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More
-
The 2025-2030 World Outlook for Immunoassays for Cancer and Tumor Profiling
The 2025-2030 World Outlook for Immunoassays for Cancer and Tumor Profiling This study covers the world outlook for immunoassays for cancer and tumor profiling across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ... Read More
-
The 2025-2030 World Outlook for Leukemia Treatments
The 2025-2030 World Outlook for Leukemia Treatments This study covers the world outlook for leukemia treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Chronic Myelogenous Leukemia Treatments
The 2025-2030 World Outlook for Chronic Myelogenous Leukemia Treatments This study covers the world outlook for chronic myelogenous leukemia treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the ... Read More
-
The 2025-2030 World Outlook for Lung Cancer Surgeries
The 2025-2030 World Outlook for Lung Cancer Surgeries This study covers the world outlook for lung cancer surgeries across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
Research Assistance
